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Background: Five observational studies from Canada found an association between seasonal influenza vaccine
receipt and increased risk of pandemic influenza H1N1 2009 infection. This association remains unexplained.
Although uncontrolled confounding has been suggested as a possible explanation, the nature of such confounding
has not been identified. Observational studies of influenza vaccination can be affected by confounding due to
healthy users and the influence of social determinants on health. The purpose of this study was to investigate the
influence that these two potential confounders may have in combination with temporary immunity, using stratified
tables. The hypothesis is that respiratory virus infections may activate a temporary immunity that provides short-
term non-specific protection against influenza and that the relationship with being a healthy user or having a social
determinant may result in confounding.
Methods: We simulated the effect of confounding on vaccine effectiveness assuming that this could result from
both social determinants and healthy user effects as they both influence the risk of seasonal influenza and non-
influenza respiratory virus infections as well as the likelihood of being vaccinated. We then examined what impact
this may have had on measurement of seasonal influenza vaccine effectiveness against pandemic influenza.
Results: In this simulation, failure to adjust for healthy users and social determinants would result in an erroneously
increased risk of pandemic influenza infection associated with seasonal influenza vaccination. The effect sizes were
not however large.* Correspondence: Natasha.crowcroft@oahpp.ca
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http://www.biomedcentral.com/1471-2458/12/458Conclusions: We found that unmeasured healthy user effects and social determinants could result in an apparent
association between seasonal influenza vaccine and pandemic influenza infection by virtue of being related to
temporary immunity. Adjustment for social determinants of health and the healthy user effects are required in
order to improve the quality of observational studies of influenza vaccine effectiveness.
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Five observational studies carried out during the 2009
pandemic of influenza A H1N1 (pH1N1) in Canada
found that previous 2008-9 seasonal influenza vaccine
appeared to increase risk of being infected with the
pandemic virus [1,2]. No significant methodological
flaws were identified; unmeasured confounding was,
however, the most common explanation for the
observed association. Observational studies of seasonal
influenza vaccination have been shown to be affected
by confounding due to healthy-user effects and social
determinants [3,4]. Such unmeasured confounding is
unlikely to be the whole explanation given the preva-
lence and strength of association needed to explain the
observations [5]. Heath Kelly and colleagues demon-
strated a potential biological mechanism to explain the
findings [6] in an elegant analysis. They postulated that
a temporary cross-protective effect against pandemic
influenza might have resulted from increased rates of
seasonal influenza infection occurring in unvaccinated
individuals in the months just prior to the start of the
pandemic, when seasonal influenza was indeed circulat-
ing in Canada. They acknowledged however that the
resulting effect sizes using realistic parameters were not
large enough to explain what was observed in Canada.
The idea of a temporary cross-protective effect is how-
ever consistent with no similar risk being reported by
the same Canadian partnership in the second pandemic
wave in Canada [7].
Cross-protection between influenza strains may have
a number of mechanisms that could result in such a
finding. Before carrying out expensive and invasive
experiments to look for such biological effects it can
be helpful to explore in simulations non-biological
explanations. We carried out an exploration of how
activation of a temporary cross-reactive immune re-
sponse might explain the findings if it were an effect
of Influenza-like-illness (ILI) caused by any respiratory
infection (not solely influenza) operating via con-
founding by healthy-user effects and social determi-
nants. Healthy users are more likely to be vaccinated
and also less likely to acquire seasonal influenza mak-
ing them potentially more at risk for pH1N1 due to
the fact that they would be less likely to have tempor-
ary immunity. On the other spectrum, social
deprivation has been shown to be related to a
reduced uptake to seasonal influenza vaccination [8,9]as well as an increased risk of becoming ill due to re-
spiratory infections including influenza [Lowcock EC
et al. in press] [10]. We aimed to recreate the
observed link between seasonal vaccine and pandemic
H1N1 in a case control study assuming that the
underlying distribution of individuals in social deter-
minants and healthy user categories would have differ-
ential effects on both vaccine uptake and as a result
in protective temporary immunity that could explain
the observed positive association.
Methods
We defined a confounder as a third factor which is
related to both exposure (seasonal influenza vaccin-
ation) and outcome (pandemic influenza), and accounts
for some or all of the observed relationship between
the two (Figure 1). We constructed stratified results of
a hypothetical case control study of 1000 subjects with
a study design ratio of cases to controls of 1:1 (i.e. 500
in each group). In order to investigate the role of two
unmeasured confounders, we stratified the case control
population by healthy users (yes or no) and social
determinants (present or not). To construct the under-
lying pre-pandemic distribution we assumed the effect
of social determinants is to make people both less
likely to be vaccinated and more likely to get sick and
tested for seasonal influenza and other respiratory
infections (confounding that results in a bias in favour
of the seasonal vaccine). In a standard 2 by 2 table
(Figure 2) comparing seasonal influenza vaccination
status and pH1N1 case/control status, this would move
people from cell a to c because we would expect to
have recruited more unvaccinated cases with social
determinants. We used an effect size that would drop
vaccination coverage among those with the social
determinants from 40% to 20%, potentially doubling
risk of influenza (Table 1) and assumed this social
determinants effect to be present in 20% of the popula-
tion (Lowcock EC et al. In Press). We assumed that
healthy users are more likely to be vaccinated and less
likely to get seasonal influenza (Figure 2). This con-
founding also results in a bias in favour of vaccine, and
moves people from cell d to b in the 2 by 2 because
we would expect to have recruited more healthy users.
We used an effect size of an absolute increase by 10%
in seasonal influenza vaccine coverage among healthy
users and a prevalence of 32% in the population,
Figure 1 Effect of temporary immunity and biases associated with seasonal influenza vaccination.
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population that remains after excluding the 30% report-
ing a chronic disease [11]. For simplicity, we assumed
that healthy users and those with social determinants
are mutually exclusive and that case and control distri-
bution remains 1:1 overall. We assumed that non-
influenza respiratory infection would have the same
qualitative effect on temporary immunity as influenza,
whereby higher rates of both influenza and non-
influenza respiratory infection caused by social determi-
nants would increase protection from subsequent
pH1N1 and lower rates of seasonal and non-influenza
respiratory infections would increase susceptibility of
healthy users. We set the impact of both influenza and
non-influenza respiratory infections on temporary im-
munity equivalent to a 10% change in the distribution
of cases and controls within a stratum. Baseline vaccin-
ation coverage was taken to be 40% based on Ontario’s
Universal Influenza Immunization Program (UIIP) [12].
We assumed that being a healthy user does not how-
ever directly reduce the risk of pH1N1 because this isa susceptible population and so the force of infection
would be high in most age groups. We ignored the im-
pact of pre-existing immunity in older age groups [13].
The baseline assumptions used to create the pre-
pandemic population are shown in Table 1. We set the
seasonal vaccine vaccine effectiveness at approximately
60% and assumed it had no effect on the risk of ac-
quiring pandemic H1N1 (i.e. odds ratio equal to 1).
The odds ratio derived from the summary Table 2 is
deliberately calculated incorrectly, such that the effect
of confounding by healthy users and social determi-
nants is ignored, and thereby demonstrates what would
be observed if confounding were not taken into ac-
count. We then calculated the odds ratio correctly
using the Mantel Haenszel method to show the impact
of accounting for these confounding factors [14].
We stratified the 500 cases and 500 controls based on
the assumptions in Table 1 and re-constructed the vac-
cine effectiveness that was observed previously for sea-
sonal influenza [3]. We populated the 2 by 2 tables










Totals a+c b+d a+b+c+d
Social determinants: Bias in the direction of lower vaccine uptake (20%versus 40%
baseline)and higher ratesof respiratory infection(20%higher);over estimates vaccine
effectiveness
Healthyusers:Bias in thedirection of higher vaccine uptake(50%versus40% baseline)
andlower rates of respiratory infection(20% fewer); under estimates vaccine
effectiveness
Figure 2 A standard two-by-two table with a demonstration of the different effects of the healthy user effect and social determinants
on the distribution of cases and controls and their vaccination status.
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measured effects of healthy users and social determinants
would influence both vaccine uptake and likelihood of
acquiring temporary immunity through seasonal influenza
infection and non-influenza respiratory infections prior to




Proportion of the population with a social
determinant that would confound the association)
12%
Proportion of the population classified as
healthy users
40%
Seasonal vaccine baseline coverage 40%
Effect sizes Vaccination coverage among the population
with social determinants (half baseline coverage)
10%
Proportion of controls that would be classified as
cases due to having social determinants
20%
Vaccination coverage among population of
healthy users (10% above baseline)
50%
Proportion of cases that would be classified as
controls due to being a healthy users
20%
Seasonal influenza vaccine effectiveness
against seasonal influenza
60%
Additional effect of non-influenza ILI 10%Results
Using the baseline assumptions to re-create the post-
pH1N1 wave 1 associations and assumptions about the
prevalence of healthy users and those with social deter-
minants, an unadjusted odds ratio of 1.3 (95% CI: 1.0 to
1.7) would result between seasonal influenza vaccine and
pandemic infection. The two confounding factors each
had their own independent influence on pH1N1 based
on our assumptions such that healthy users were twice
as likely to be vaccinated against seasonal influenza
(OR= 2.0, 95% CI: 1.5 to 2.6) and four times more likely
to test positive for pH1N1 (OR= 4.0, 95% CI: 3.1 - 5.3).
Those with social determinants were 70% less likely to
be vaccinated against seasonal influenza (OR= 0.31, 95%
CI: 0.21 to 0.44) and 65% less likely to test positive for
pH1N1 (OR= 0.35, 95% CI: (0.25 TO 0.49) due to cross-
protected immunity. Stratum-specific odds ratios are
equal to 1 due to the fact that we assumed no effect
modification. After accounting for the unmeasured
effects of being a healthy user and having social determi-
nants using the Mantel Haenszel method, this associ-
ation would be reduced from 1.3 to 1.0 with the final
association being non-significant (95% CI: 0.8 to 1.3). In-
creasing the sample size to 10,000 did slightly reduce the
confidence intervals (Unadjusted OR=1.3 95% CI: 1.2 to
Table 2 Seasonal influenza vaccination and H1N1 infection stratified by healthy users and social determinants
Healthy User = 0 Social Determinant = 1 H1N1 Total
+ -
Vaccinated + 12 28 40
- 48 112 160
60 140 200
Healthy User = 1 Social Determinant = 1 H1N1 Total
+ -
Vaccinated + 140 60 200
- 140 60 200
280 120 400
Healthy User = 0 Social Determinant = 0 H1N1 Total
+ -
Vaccinated + 64 96 160





Vaccinated + 216 184 400 OR} =1.3
- 284 316 600 95% CI: 1.0 to 1.7
500 500 1000 OR M-H = 1.0
95% CI: 0.8 to 1.3
Adjusted for healthy user and social determinants using the Mantel Haenszel method.
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secondary analysis assuming various levels of co-
occurrence between social determinants and healthy
users but because the effects were opposing each other
this did not significantly change the overall finding. Fur-
thermore, these confounders are unlikely to co-occur so
any influence would be expected to be minimal.
Discussion
The potential for unmeasured confounding exists in any
observational design. Exploring the nature of this uncer-
tainty is important to the interpretation of observational
studies to assess vaccine effectiveness [15]. This study
demonstrates a simple way to reveal the potential impact
of unmeasured confounding that is related to temporary
immunity on estimates of vaccine effectiveness using
stratified tables. Overall we show that the presence of
unmeasured confounder that is related to temporary im-
munity could possible bias the risk estimates away from
the null and that this would result negatively for sea-
sonal influenza (positive VE) and positively for pH1N1
(negative VE). The observed odds ratios are lower than
what was observed in the studies by Skowronski et al.
[1]; however, the direction of effect is consistent such
that a protective effect for seasonal influenza and an
increased risk for pandemic influenza may be observed.
We have to acknowledge that this is an artificial,simplified and constructed scenario with a range of
assumptions that are subject to uncertainty. Further-
more, it is possible that the baseline assumptions may
differ from what was observed during the pandemic, but
we believe them to be within a reasonable range of what
is observed through a number of different data sources.
This should be conceptualized as a thought experiment
that illustrates the effect of confounding that is related to
temporary immunity in a way that might be helpful for
epidemiologists in the field.
Some unique circumstances during the 2009 pandemic
in Canada may have affected the observations made, in-
cluding the close timing of the first wave in relation to
the end of the previous winter season of respiratory
infections. Modelling has shown that this timing is crit-
ical [16]. It is also worth noting that winter regularly
brings a mixture of different influenza and other respira-
tory viruses. If it is true that the activation of temporary
immunity by one respiratory virus might affect suscepti-
bility to others, then this effect may operate to a greater
or lesser extent during every influenza season, and
would also be likely to vary during any given season.
Given the relationship between respiratory infections
and vaccination, there is significant potential for this to
be an important contributor to unexplained variation in
observed vaccine effectiveness. Such variation includes
apparent lack of concordance between influenza strain
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drawn about the biology of temporary immunity from
this study, but these findings support further immuno-
logical research into potential mechanisms.
If unmeasured confounding distorts observations of
vaccine effectiveness this creates a huge challenge for in-
fluenza epidemiologists. The influenza vaccine can be
confounded more so than other vaccine exposures due
to the fact that the uptake is not universal in all popula-
tions. Influenza vaccine uptake will vary according to
health care access, indications, occupations and under-
lying medical conditions, all of which can also influence
the likelihood of acquiring influenza.
Confounding is most effectively addressed either
through design or through measurement so that we can
adjust for its effects during the analysis. It is much harder
to design out confounding in observational studies com-
pared to randomized controlled trials. For observational
studies on vaccine effectiveness the best solution is to
measure confounders and adjust for them in the analysis.
This requires greater sample size as well as the ability to
accurately measure confounders using feasible and re-
producible methods. Other methods to address unmeas-
ured confounding include sensitivity analyses [4,11] and
simulation [12,17], which require complex approaches as
well as good baseline data into assumptions of potential
confounders that exist in the population.
This analysis is subject to baseline assumptions and
furthermore did not consider joint or multiplicative
effects; thus, may not reflect the situation during the
2009 pandemic. Nevertheless it demonstrates that failure
to control for confounders that may bias the associations
with the seasonal influenza vaccine (or the pandemic in-
fluenza vaccine) will affect the measures of associations.
Furthermore these measures of associations can influ-
ence different respiratory outcomes (i.e. seasonal influ-
enza versus pandemic influenza) differently.Conclusions
Further research is needed into methods that can more
completely measure social and behavioural confounders
in influenza vaccine effectiveness studies and can be
integrated easily into public health surveillance. Until
this can be accomplished, questions will always remain
about the validity of influenza vaccine effectiveness esti-
mates derived from observational studies.
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